Journal of Laboratory Medicine and Quality Assurance

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-7261   pISSN 2384-2458

Table. 6.

Table. 6.

Methods and results of human leukocyte antigen crossmatching

TrialSpecimen MethodsTotalNegativePositive1:11:21:41:81:161:32>1:32 Intended response
1stIX-18-01+IX-18-03T-CDC-Direct45450Code 505
T-CDC-AHG453872311Code 505
T-FCM342311Code 505
B-CDC-Direct1912722111Code 505
B-FCM23419Positive
IX-18-01+IX-18-04T-CDC-Direct4542312Negative
T-CDC-AHG4541413Negative
T-FCM34322Negative
B-CDC-Direct192171493Positive
B-FCM23023Positive
IX-18-02+IX-18-03T-CDC-Direct4504532112252Positive
T-CDC-AHG450452272311Positive
T-FCM34034Positive
B-CDC-Direct190192134Positive
B-FCM23023Positive
IX-18-02+IX-18-04T-CDC-Direct45450Negative
T-CDC-AHG45450Negative
T-FCM34331Negative
B-CDC-Direct1911813211Code 505
B-FCM23122Positive
2ndIX-18-05+IX-18-07T-CDC-Direct45450Code 505
T-CDC-AHG464511Code 505
T-FCM34277Code 505
B-CDC-Direct18117313Code 505
B-FCM22616Code 505
IX-18-05+IX-18-08T-CDC-Direct4554038825113Positive
T-CDC-AHG4614534471512Positive
T-FCM34034Positive
B-CDC-Direct18018121104Positive
B-FCM22022Positive
IX-18-06 +IX-18-07T-CDC-Direct4531147421Code 505
T-CDC-AHG46442611106351Positive
T-FCM34034Positive
B-CDC-Direct18414234113Positive
B-FCM22319Positive
IX-18-06+IX-18-08T-CDC-Direct454411Negative
T-CDC-AHG464511Negative
T-FCM34340Negative
B-CDC-Direct181711Negative
B-FCM22211Negative

Abbreviations: T-CDC, T cell-complement dependent cytotoxicity; AHG, anti-human globulin; FCM, flow cytometry; B-CDC, B cellcomplement dependent cytotoxicity.

J Lab Med Qual Assur 2019;41:130-52 https://doi.org/10.15263/jlmqa.2019.41.3.130
© 2019 J Lab Med Qual Assur